263 related articles for article (PubMed ID: 24751585)
1. Alzheimer's and Parkinson's diseases: an environmental proteomic point of view.
Demartini DR; Schilling LP; da Costa JC; Carlini CR
J Proteomics; 2014 Jun; 104():24-36. PubMed ID: 24751585
[TBL] [Abstract][Full Text] [Related]
2. Proteomics and Neurodegenerative Disorders: Advancements in the Diagnostic Analysis.
Puranik N; Yadav D; Yadav SK; Chavda VK; Jin JO
Curr Protein Pept Sci; 2020; 21(12):1174-1183. PubMed ID: 32392110
[TBL] [Abstract][Full Text] [Related]
3. Proteomic Analysis of the Human Olfactory Bulb.
Dammalli M; Dey G; Madugundu AK; Kumar M; Rodrigues B; Gowda H; Siddaiah BG; Mahadevan A; Shankar SK; Prasad TSK
OMICS; 2017 Aug; 21(8):440-453. PubMed ID: 28816642
[TBL] [Abstract][Full Text] [Related]
4. Application of Contemporary Neuroproteomic Techniques in Unravelling Neurological Disorders.
Khurana M; Rahman SO; Najmi AK; Pottoo FH; Akhtar MS
Curr Protein Pept Sci; 2020; 21(12):1146-1163. PubMed ID: 33148155
[TBL] [Abstract][Full Text] [Related]
5. Proteomics of neurodegenerative diseases: analysis of human post-mortem brain.
Li KW; Ganz AB; Smit AB
J Neurochem; 2019 Nov; 151(4):435-445. PubMed ID: 30289976
[TBL] [Abstract][Full Text] [Related]
6. Peripheral Biomarkers for Early Detection of Alzheimer's and Parkinson's Diseases.
Htike TT; Mishra S; Kumar S; Padmanabhan P; Gulyás B
Mol Neurobiol; 2019 Mar; 56(3):2256-2277. PubMed ID: 30008073
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases.
Cilento EM; Jin L; Stewart T; Shi M; Sheng L; Zhang J
J Neurochem; 2019 Nov; 151(4):397-416. PubMed ID: 30474862
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of the serum/plasma proteome identifies significant associations between COVID-19 with Alzheimer's/Parkinson's diseases.
Mahin A; Soman SP; Modi PK; Raju R; Keshava Prasad TS; Abhinand CS
J Neurovirol; 2024 Feb; 30(1):57-70. PubMed ID: 38167982
[TBL] [Abstract][Full Text] [Related]
9. Neuroproteomics tools in clinical practice.
Shevchenko G; Konzer A; Musunuri S; Bergquist J
Biochim Biophys Acta; 2015 Jul; 1854(7):705-17. PubMed ID: 25680928
[TBL] [Abstract][Full Text] [Related]
10. Biomarker discovery in neurodegenerative diseases: a proteomic approach.
Shi M; Caudle WM; Zhang J
Neurobiol Dis; 2009 Aug; 35(2):157-64. PubMed ID: 18938247
[TBL] [Abstract][Full Text] [Related]
11. Environmental radon daughters reveal pathognomonic changes in the brain proteins and lipids in patients with Alzheimer's disease and Parkinson's disease, and cigarette smokers.
Momcilović B; Alkhatib HA; Duerre JA; Cooley MA; Long WM; Harris RT; Lykken GI
Arh Hig Rada Toksikol; 1999 Dec; 50(4):347-69. PubMed ID: 10851740
[TBL] [Abstract][Full Text] [Related]
12. Proteomics in human Parkinson's disease research.
Licker V; Kövari E; Hochstrasser DF; Burkhard PR
J Proteomics; 2009 Nov; 73(1):10-29. PubMed ID: 19632367
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins.
Butterfield DA; Palmieri EM; Castegna A
Expert Rev Proteomics; 2016; 13(3):259-74. PubMed ID: 26837425
[TBL] [Abstract][Full Text] [Related]
14. Applications of iTRAQ and TMT Labeling Techniques to the Study of Neurodegenerative Diseases.
Li K; Chen Z; Zhang Y; Yang X
Curr Protein Pept Sci; 2020; 21(12):1202-1217. PubMed ID: 33143625
[TBL] [Abstract][Full Text] [Related]
15. Molecular biomarkers of neurodegeneration.
Höglund K; Salter H
Expert Rev Mol Diagn; 2013 Nov; 13(8):845-61. PubMed ID: 24151849
[TBL] [Abstract][Full Text] [Related]
16. Editorial to the Special Issue "Lipidomics and Neurodegenerative Diseases".
Calvano CD; Losito I; Cataldi T
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525336
[TBL] [Abstract][Full Text] [Related]
17. Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia.
Trojanowski JQ; Goedert M; Iwatsubo T; Lee VM
Cell Death Differ; 1998 Oct; 5(10):832-7. PubMed ID: 10203692
[TBL] [Abstract][Full Text] [Related]
18. Proteomics Approach to Identify Biomarkers in Neurodegenerative Diseases.
Nayak A; Salt G; Verma SK; Kishore U
Int Rev Neurobiol; 2015; 121():59-86. PubMed ID: 26315762
[TBL] [Abstract][Full Text] [Related]
19. Proposed biochemistry of Parkinson's and Alzheimer's diseases.
Robertson DS
Med Hypotheses; 2017 Nov; 109():131-138. PubMed ID: 29150272
[TBL] [Abstract][Full Text] [Related]
20. Proteomics in animal models of Alzheimer's and Parkinson's diseases.
Sowell RA; Owen JB; Butterfield DA
Ageing Res Rev; 2009 Jan; 8(1):1-17. PubMed ID: 18703168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
